Taxolog, Inc.
🇺🇸United States
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Taxolog Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT00685204
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸New York University Cancer Center, New York, New York, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath